Delivery Order SPE2DB20D3101-SPE2DB21FJ8U8

Award Date 7/7/21
Potential Completion Date 7/8/21
Potential Value $6.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a $999,999,999 Indefinite Delivery Contract (IDC) that runs through November 2026. It is used to efficiently procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical...
This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00, and runs through December 2025. This Indefinite Delivery Contract (IDC) serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This Indefinite Delivery Contract (IDC) enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, is for the prime vendor supply of a broad range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The...
This federal contract award is for a pharmaceutical prime vendor contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award is for a prime vendor pharmaceutical contract valued at $1,829.75, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including...
This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through December 2025. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for $1,433.28 to provide pharmaceutical and medical supplies as a prime vendor to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products, including...
This federal contract award is for pharmaceutical and medical supply services provided by Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The IDC runs through November 2026 and covers a comprehensive range of pharmaceutical and medical commodities, including specialty medications, brand-name and generic...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical supplies. The contract is a Firm Fixed Price Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of essential medical commodities, including specialty medications,...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB21FJ8U8
    Delivery Order

This federal contract award is for a pharmaceutical prime vendor supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through November 2026. It provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs. These contracts demonstrate Amerisourcebergen's significant role as a critical supplier of essential pharmaceutical and medical commodities to various federal government agencies.

Generated 2/27/25, 10:22 AM